183 related articles for article (PubMed ID: 34942879)
1. Anti-Ma2 Antibody-Associated Paraneoplastic Neurological Syndromes: A Pilot Study.
Guo Y; Cai MT; Lai QL; Zheng Y; Shen CH; Zhang YX
Brain Sci; 2021 Nov; 11(12):. PubMed ID: 34942879
[TBL] [Abstract][Full Text] [Related]
2. [Anti-Ma2-associated encephalitis and paraneoplastic limbic encephalitis].
Yamamoto T; Tsuji S
Brain Nerve; 2010 Aug; 62(8):838-51. PubMed ID: 20714032
[TBL] [Abstract][Full Text] [Related]
3. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
[TBL] [Abstract][Full Text] [Related]
4. Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors.
Vogrig A; Fouret M; Joubert B; Picard G; Rogemond V; Pinto AL; Muñiz-Castrillo S; Roger M; Raimbourg J; Dayen C; Grignou L; Pallix-Guyot M; Lannoy J; Ducray F; Desestret V; Psimaras D; Honnorat J
Neurol Neuroimmunol Neuroinflamm; 2019 Nov; 6(6):. PubMed ID: 31454760
[TBL] [Abstract][Full Text] [Related]
5. A single center retrospective study of paraneoplastic neurological syndromes with positive onconeural antibodies.
Fu P; He L; Tang N; Nie Q; Li Z
J Clin Neurosci; 2021 Jul; 89():336-342. PubMed ID: 34119290
[TBL] [Abstract][Full Text] [Related]
6. Anti-Ma and anti-Ma2-associated paraneoplastic neurological syndromes.
Ortega Suero G; Sola-Valls N; Escudero D; Saiz A; Graus F
Neurologia (Engl Ed); 2018; 33(1):18-27. PubMed ID: 27460184
[TBL] [Abstract][Full Text] [Related]
7. Clinical Spectrum, Therapeutic Outcomes and Prognostic predictors in Paraneoplastic Neurological Syndromes - Experiences from a Tertiary Care Center in India.
Vijayaraghavan A; Alexander PT; Nair AV; Sivadasan A; Mani AM; Mathew D; Shaikh A; Benjamin RN; Prabhakar AT; Jude J; Mani S; Aaron S; Mathew V; Alexander M
Ann Indian Acad Neurol; 2021; 24(1):32-39. PubMed ID: 33911377
[TBL] [Abstract][Full Text] [Related]
8. [Anti-Ma2 paraneoplastic autoimmune encephalitis].
Chekanova EO; Simaniv TO; Evdokimenko AN; Zakharova MN
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(7. Vyp. 2):89-95. PubMed ID: 35912563
[TBL] [Abstract][Full Text] [Related]
9. Immunopathogenesis and proposed clinical score for identifying Kelch-like protein-11 encephalitis.
Vogrig A; Péricart S; Pinto AL; Rogemond V; Muñiz-Castrillo S; Picard G; Selton M; Mittelbronn M; Lanoiselée HM; Michenet P; Benaiteau M; Pariente J; Zéphir H; Giordana C; Montaut S; Salhi H; Bachoumas P; Montcuquet A; Letovanec I; Uro-Coste E; Honnorat J
Brain Commun; 2021; 3(3):fcab185. PubMed ID: 34557666
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study.
Oliveira V; Videira G; Samões R; Carneiro P; Neves E; Santos E
J Neurol Sci; 2020 Nov; 418():117103. PubMed ID: 32877801
[TBL] [Abstract][Full Text] [Related]
11. [Neurological syndromes, encephalitis].
Yamamoto T; Tsuji S
Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
[TBL] [Abstract][Full Text] [Related]
12. Low-dose interleukin-2 as a novel therapeutic option for refractory paraneoplastic neurologic syndrome: a case of chronic relapsing anti-Ma2/Ta paraneoplastic myeloradiculopathy.
Ahn SJ; Lee HS; Lee WJ; Chu K
Encephalitis; 2021 Jul; 1(3):79-84. PubMed ID: 37469846
[TBL] [Abstract][Full Text] [Related]
13. Clinical analysis of anti-Ma2-associated encephalitis.
Dalmau J; Graus F; Villarejo A; Posner JB; Blumenthal D; Thiessen B; Saiz A; Meneses P; Rosenfeld MR
Brain; 2004 Aug; 127(Pt 8):1831-44. PubMed ID: 15215214
[TBL] [Abstract][Full Text] [Related]
14. Screening for anti-titin antibodies in patients with various paraneoplastic neurological syndromes.
Berger B; Stich O; Labeit S; Rauer S
J Neuroimmunol; 2016 Jun; 295-296():18-20. PubMed ID: 27235344
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic neurological syndromes.
Honnorat J; Antoine JC
Orphanet J Rare Dis; 2007 May; 2():22. PubMed ID: 17480225
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer.
Rojas-Marcos I; Rousseau A; Keime-Guibert F; Reñé R; Cartalat-Carel S; Delattre JY; Graus F
Medicine (Baltimore); 2003 May; 82(3):216-23. PubMed ID: 12792307
[TBL] [Abstract][Full Text] [Related]
17. Motor neuron involvement in anti-Ma2-associated paraneoplastic neurological syndrome.
Vogrig A; Joubert B; Maureille A; Thomas L; Bernard E; Streichenberger N; Cotton F; Ducray F; Honnorat J
J Neurol; 2019 Feb; 266(2):398-410. PubMed ID: 30498914
[TBL] [Abstract][Full Text] [Related]
18. Anti-Ma2 antibody encephalitis associated with Sjogren's syndrome.
Chevalier K; Noel N; Benoudiba F; Chrétien P; Hacein-Bey-Abina S; Lambotte O
Rev Med Interne; 2021 Aug; 42(8):575-578. PubMed ID: 34052049
[TBL] [Abstract][Full Text] [Related]
19. Distinct clinical characteristics of paraneoplastic optic neuropathy.
Xu Q; Du W; Zhou H; Zhang X; Liu H; Song H; Wang X; Wei S
Br J Ophthalmol; 2019 Jun; 103(6):797-801. PubMed ID: 30021813
[TBL] [Abstract][Full Text] [Related]
20. Parkinsonism and dysautonomia with anti-CV2/CRMP5 associated paraneoplastic neurological syndromes mimicking multiple system atrophy: a case report.
Song J; Zhang Y; Lang Y; Wang YH; Shao J; Cui L
BMC Neurol; 2021 Oct; 21(1):408. PubMed ID: 34702214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
